CILcare

Takeda Pharmaceutical Company Limited is a global pharmaceutical leader headquartered in Japan, with a strong presence in the United States. With a focus on innovation and patient care, Takeda is dedicated to transforming the healthcare industry and improving the lives of patients and physicians worldwide. Through its diverse portfolio of products and commitment to sustainability, Takeda aims to address key societal challenges and create value for society. With a strong emphasis on research and development, Takeda is at the forefront of medical advancements and is dedicated to providing patient services and assistance.Generated from the website

Founded in 1997, Takeda America Holdings offers various cash management and investment services. Located in New York City, Takeda America Holdings is a wholly owned subsidiary of Takeda Pharmaceutical Company, which discovers, develops, manufactures and markets a broad range of pharmaceutical products. Takeda Pharmaceutical Company sells its products in more than 100 countries under various brands names, including Lupron Depot, Enantone, Prostap and Leuplin, Prevacid, Ogast, Takepron, Blopress, Kenzen and Amias. Its research and development team works with other pharmaceutical manufacturers, biotechnology companies, universities and research institutions to promote medical drugs. The company also operates facilities in France, Germany, Austria, Ireland, China, Taiwan, Indonesia and Thailand.

Founded in April 2006, Concert Pharmaceuticals is a clinical stage biotechnology company based in Lexington, Mass. It creates medicines through a scientific approach utilizing the naturally occurring element deuterium. Concert Pharmaceuticals Inc. has raised $110 million since its inception. The company has over 100 patent applications for new drug candidates addressing a broad range of therapeutic areas, including HIV/AIDS, and renal disease, among others. USPTO granted Concert Pharmaceutical s first patents in 2009. Some of the company s investors include Brookside Capital Partners Fund, TVM Capital, Three Arch Partners, Fidelity Investments, Skyline Ventures, Flagship Ventures, Adage Capital Management and New Leaf Venture Partners.